Neuropacs CSO David Vaillancourt to lead $22 million NIH Alzheimer’s grant

Neuropacs said its co-founder and chief scientific officer, Dr. David Vaillancourt, will serve as a key scientific leader in a $22 million NIH grant supporting the University of Florida-led Alzheimer’s Disease Research Center. The award supports imaging cohorts, biomarker studies and multi-site clinical collaborations.